Regeneus director supports stem cell technology through on-market purchase – Proactive Investors Australia
Proactive Investors Australia |
Regeneus director supports stem cell technology through on-market purchase
Proactive Investors Australia Regeneus Ltd's (ASX:RGS) recently appointed Japanese-based non-executive director, Leo Lee, has demonstrated his confidence in the company's stem cell technology platform through an on-market purchase of shares. Lee purchased 1,011,000 shares for a … |
